Research & Development
FDA grants priority review to ifinatamab deruxtecan in small cell lung cancer
13 April 2026 - US pharmaceutical company Merck & Co Inc (NYSE:MRK), known as MSD outside the US and Canada, and Japanese healthcare company Daiichi Sankyo Co Ltd (TYO:4568) announced on Monday th...
EU approves Sanofi and Regeneron's Dupixent for young children with chronic spontaneous urticaria
13 April 2026 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) and US biotechnology company Regeneron Pharmaceuticals Inc (Nasdaq:REGN) announced on Monday that they have rece...
Apotex's generic Ozempic (Semaglutide Injection) receives US FDA tentative approval
13 April 2026 - Canadian pharmaceutical company Apotex Inc announced on Friday that its US subsidiary Apotex Corp has received the first US Food and Drug Administration (FDA) tentative approval for it...
Lupin's Dapagliflozin Tablets launched in US market
13 April 2026 - India-based global pharmaceutical company Lupin Limited (BSE:500257) (NSE:LUPIN) announced on Friday the launch of Dapagliflozin Tablets, 5 mg and 10 mg, in the United States.Lupin...
Verastem Oncology presents two-year follow-up data on avutometinib and defactinib in recurrent low-grade serous ovarian cancer
10 April 2026 - Biopharmaceutical company Verastem Oncology (Nasdaq:VSTM) on Friday announced two-year median follow-up results from the Phase 2 RAMP 201 clinical trial of Avmapki Fakzynja combination...
DualityBio reports China NMPA acceptance of BLA for T-Pam for treatment of unresectable or metastatic HER2-positive breast cancer
10 April 2026 - Chinese biopharmaceutical company DualityBio (HK:9606) announced on Thursday that the Biologics License Application (BLA) for the investigational antibody-drug conjugate (ADC) trastuzu...